Our current findings significantly expand the known functions of eHsp90-LRP1 in malignancy and define crosstalk with AKT-EphA2 as a novel and essential mechanism for eHsp90-mediated pro-motility function in GBM. The gene discussed is AKT1; the disease is glioblastoma.